Ivan Jerković1, Toni Ljubić, Željana Bašić, Ivana Kružić, Nenad Kunac, Joško Bezić, Arijana Vuko, Alemka Markotić, Šimun Anđelinović. 1. University Department of Forensic Sciences, University of Split, Split, Croatia (Jerković, Ljubić, Bašić, Kružić); Clinical Department for Pathology, Forensic Medicine and Cytology, University Hospital Center Split, Split, Croatia (Kunac, Bezić, Vuko, Anđelinović); Dr Fran Mihaljević University Hospital for Infectious Diseases, Zagreb, Croatia (Markotić); Catholic University of Croatia, Zagreb, Croatia (Markotić); University of Rijeka School of Medicine, Rijeka, Croatia (Markotić); University of Split, School of Medicine, Split, Croatia (Anđelinović).
Abstract
OBJECTIVES: To examine seroprevalence of SARS-CoV-2 antibodies in industry workers population sample. METHODS: From 23 to 28 April 2020, we conducted serological testing for antibodies (IgG and IgM) on 1494 factory employees living in the Split-Dalmatia and Šibenik-Knin County (Croatia). RESULTS: We detected antibodies in 1.27% of participants (95% CI 0.77-1.98%). In Split facility 13/1316 (0.99%, 95% CI 0.53-1.68%) of participants were tested positive, of which 13/1079 (1.20%, 95% CI 0.64-2.05%) of those living outside the facility and 0/237 (0%, 95% CI 0-1.26%) of those living inside the facility. In Knin facility, 6/178 (3.37%, 95% CI 1.25-7.19%) participants were tested positive for antibodies. CONCLUSIONS: The study showed relatively small SARS-CoV-2 antibody seroprevalence in the DIV Group population sample.
OBJECTIVES: To examine seroprevalence of SARS-CoV-2 antibodies in industry workers population sample. METHODS: From 23 to 28 April 2020, we conducted serological testing for antibodies (IgG and IgM) on 1494 factory employees living in the Split-Dalmatia and Šibenik-Knin County (Croatia). RESULTS: We detected antibodies in 1.27% of participants (95% CI 0.77-1.98%). In Split facility 13/1316 (0.99%, 95% CI 0.53-1.68%) of participants were tested positive, of which 13/1079 (1.20%, 95% CI 0.64-2.05%) of those living outside the facility and 0/237 (0%, 95% CI 0-1.26%) of those living inside the facility. In Knin facility, 6/178 (3.37%, 95% CI 1.25-7.19%) participants were tested positive for antibodies. CONCLUSIONS: The study showed relatively small SARS-CoV-2 antibody seroprevalence in the DIV Group population sample.
Authors: Tatjana Vilibic-Cavlek; Ljubo Barbic; Anna Mrzljak; Dragan Brnic; Ana Klobucar; Maja Ilic; Natasa Janev-Holcer; Maja Bogdanic; Lorena Jemersic; Vladimir Stevanovic; Irena Tabain; Stjepan Krcmar; Marko Vucelja; Jelena Prpic; Marko Boljfetic; Pavle Jelicic; Josip Madic; Ivana Ferencak; Vladimir Savic Journal: Pathogens Date: 2021-01-15
Authors: Mathias Peirlinck; Kevin Linka; Francisco Sahli Costabal; Jay Bhattacharya; Eran Bendavid; John P A Ioannidis; Ellen Kuhl Journal: Comput Methods Appl Mech Eng Date: 2020-09-08 Impact factor: 6.756
Authors: Tatjana Vilibic-Cavlek; Vladimir Stevanovic; Diana Brlek-Gorski; Ivana Ferencak; Thomas Ferenc; Magdalena Ujevic-Bosnjak; Irena Tabain; Natasa Janev-Holcer; Ivana Perkovic; Mario Anticevic; Barbara Bekavac; Bernard Kaic; Anna Mrzljak; Marin Ganjto; Ljiljana Zmak; Maja Mauric Maljkovic; Pavle Jelicic; Lovro Bucic; Ljubo Barbic Journal: Viruses Date: 2021-11-24 Impact factor: 5.048
Authors: Mathias Peirlinck; Kevin Linka; Francisco Sahli Costabal; Jay Bhattacharya; Eran Bendavid; John P A Ioannidis; Ellen Kuhl Journal: medRxiv Date: 2020-08-29